Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Jinsaiyu** is an orally administered traditional Chinese herbal medicine product identified as Qingwei Huazhuo Decoction. It is a multi-herb preparation being clinically evaluated with diet and exercise education for children with phlegm-dampness internal accumulation type incomplete precocious puberty. The registered study describes a powder formulation containing botanical ingredients including mulberry leaf, lotus leaf, malt, hawthorn, Poria cocos, gardenia, dried tangerine peel, licorice, and monk fruit; its molecular targets and pharmacologic mechanism have not been established. ([clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07141615))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jinsaiyu.